Literature DB >> 20130826

Involvement of SOX10 in the pathogenesis of Hirschsprung disease: report of a truncating mutation in an isolated patient.

Avencia Sánchez-Mejías1, Yuli Watanabe, Raquel M Fernández, Manuel López-Alonso, Guillermo Antiñolo, Nadege Bondurand, Salud Borrego.   

Abstract

SOX10 protein is a key transcription factor during neural crest development. Mutations in SOX10 are associated with several neurocristopathies such as Waardenburg syndrome type IV (WS4), a congenital disorder characterized by the association of hearing loss, pigmentary abnormalities, and absence of ganglion cells in the myenteric and submucosal plexus of the gastrointestinal tract, also known as aganglionic megacolon or Hirschsprung disease (HSCR). Several mutations at this locus are known to cause a high percentage of WS4 cases, but no SOX10 mutations had been ever reported associated to isolated HSCR patient. Therefore, nonsyndromic HSCR was initially thought not to be associated to mutations at this particular locus. In the present study, we describe the evaluation of the SOX10 gene in a series of 196 isolated HSCR cases, the largest patient series evaluated so far, and report a truncating c.153-155del mutation. This is the first time that a SOX10 mutation is detected in an isolated HSCR patient, which completely changes the scenario for the implications of SOX10 mutations in human disease, giving us a new tool for genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130826      PMCID: PMC3235085          DOI: 10.1007/s00109-010-0592-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  27 in total

Review 1.  Mechanisms of mRNA surveillance in eukaryotes.

Authors:  P Hilleren; R Parker
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

2.  The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences.

Authors:  R I Peirano; M Wegner
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome.

Authors:  M H Sham; V C Lui; B L Chen; M Fu; P K Tam
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

4.  Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation.

Authors:  V Pingault; A Guiochon-Mantel; N Bondurand; C Faure; C Lacroix; S Lyonnet; M Goossens; P Landrieu
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

5.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.

Authors:  N Bondurand; M Girard; V Pingault; N Lemort; O Dubourg; M Goossens
Journal:  Hum Mol Genet       Date:  2001-11-15       Impact factor: 6.150

7.  Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer.

Authors:  Deborah Lang; Jonathan A Epstein
Journal:  Hum Mol Genet       Date:  2003-04-15       Impact factor: 6.150

8.  Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.

Authors:  N Bondurand; V Pingault; D E Goerich; N Lemort; E Sock; C Le Caignec; M Wegner; M Goossens
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

9.  Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors.

Authors:  Andreas Ludwig; Stephan Rehberg; Michael Wegner
Journal:  FEBS Lett       Date:  2004-01-02       Impact factor: 4.124

10.  SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism.

Authors:  Véronique Pingault; Mathilde Girard; Nadège Bondurand; Huw Dorkins; Lionel Van Maldergem; David Mowat; Takashi Shimotake; Ishwar Verma; Clarisse Baumann; Michel Goossens
Journal:  Hum Genet       Date:  2002-07-06       Impact factor: 4.132

View more
  14 in total

Review 1.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

Review 2.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

3.  Phenotypic similarities and differences in patients with a p.Met112Ile mutation in SOX10.

Authors:  Veronique Pingault; Laurence Pierre-Louis; Asma Chaoui; Alain Verloes; Elisabeth Sarrazin; Goran Brandberg; Nadege Bondurand; Peter Uldall; Sylvie Manouvrier-Hanu
Journal:  Am J Med Genet A       Date:  2014-05-20       Impact factor: 2.802

4.  Novel mutations at RET ligand genes preventing receptor activation are associated to Hirschsprung's disease.

Authors:  Macarena Ruiz-Ferrer; Ana Torroglosa; Berta Luzón-Toro; Raquel M Fernández; Guillermo Antiñolo; Lois M Mulligan; Salud Borrego
Journal:  J Mol Med (Berl)       Date:  2011-01-05       Impact factor: 4.599

5.  Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II.

Authors:  Hua Zhang; Hongsheng Chen; Hunjin Luo; Jing An; Lin Sun; Lingyun Mei; Chufeng He; Lu Jiang; Wen Jiang; Kun Xia; Jia-Da Li; Yong Feng
Journal:  Hum Genet       Date:  2011-10-01       Impact factor: 4.132

6.  The transcription factors Ets1 and Sox10 interact during murine melanocyte development.

Authors:  Amy Saldana-Caboverde; Erasmo M Perera; Dawn E Watkins-Chow; Nancy F Hansen; Meghana Vemulapalli; James C Mullikin; William J Pavan; Lidia Kos
Journal:  Dev Biol       Date:  2015-04-23       Impact factor: 3.582

7.  Novel MLPA procedure using self-designed probes allows comprehensive analysis for CNVs of the genes involved in Hirschsprung disease.

Authors:  Avencia Sánchez-Mejías; Rocio Núñez-Torres; Raquel M Fernández; Guillermo Antiñolo; Salud Borrego
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

8.  Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness.

Authors:  Veronique Pingault; Virginie Bodereau; Viviane Baral; Severine Marcos; Yuli Watanabe; Asma Chaoui; Corinne Fouveaut; Chrystel Leroy; Odile Vérier-Mine; Christine Francannet; Delphine Dupin-Deguine; Françoise Archambeaud; François-Joseph Kurtz; Jacques Young; Jérôme Bertherat; Sandrine Marlin; Michel Goossens; Jean-Pierre Hardelin; Catherine Dodé; Nadege Bondurand
Journal:  Am J Hum Genet       Date:  2013-05-02       Impact factor: 11.025

9.  Expression of PROKR1 and PROKR2 in human enteric neural precursor cells and identification of sequence variants suggest a role in HSCR.

Authors:  Macarena Ruiz-Ferrer; Ana Torroglosa; Rocío Núñez-Torres; Juan Carlos de Agustín; Guillermo Antiñolo; Salud Borrego
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

Review 10.  Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome.

Authors:  Sida Huang; Jian Song; Chufeng He; Xinzhang Cai; Kai Yuan; Lingyun Mei; Yong Feng
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 4.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.